| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| Documento-de-consens..> | 2024-09-20 15:38 | 2.5K | ||
| Documento-de-consens..> | 2024-09-20 15:20 | 2.8K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:40 | 3.3K | ||
| LogoMSP-150x96.png | 2024-09-20 14:21 | 3.3K | ||
| Circulo-white-150x15..> | 2024-09-23 15:42 | 3.4K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:31 | 3.4K | ||
| Compartir-informes-K..> | 2024-09-20 15:20 | 4.2K | ||
| IndiceDeEstigmaKimir..> | 2024-09-20 15:23 | 4.6K | ||
| INDICE-DE-ESTIGMA-Y-..> | 2024-09-20 15:39 | 4.7K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:40 | 4.7K | ||
| INFORME-ANUAL-2018-K..> | 2024-09-23 10:31 | 4.9K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:39 | 5.1K | ||
| PFAC-ES-150x150.png | 2024-09-20 14:31 | 5.1K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:39 | 5.2K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:39 | 5.2K | ||
| INFO2023-pdf-120x150..> | 2024-09-23 10:39 | 5.3K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:39 | 5.3K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:30 | 5.3K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:39 | 5.5K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:21 | 5.5K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:24 | 5.5K | ||
| Estudio-de-prevalenc..> | 2024-09-20 15:39 | 5.5K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:40 | 5.7K | ||
| Captura-150x124.jpg | 2024-09-20 14:19 | 5.7K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:25 | 5.8K | ||
| 3DayanaQuimi-150x150..> | 2024-09-23 12:39 | 5.9K | ||
| Compartir-informes-K..> | 2024-09-20 15:20 | 5.9K | ||
| Perfil_TrabajoSexual..> | 2024-09-20 15:40 | 5.9K | ||
| Captura.jpg | 2024-09-20 14:19 | 6.0K | ||
| Orientaciones-termin..> | 2024-09-20 15:39 | 6.1K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:22 | 6.1K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:38 | 6.1K | ||
| 3-ecuador-pdf-116x15..> | 2024-09-20 15:38 | 6.2K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:39 | 6.3K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:39 | 6.5K | ||
| Effects-of-the-Front..> | 2024-09-20 15:38 | 6.5K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:26 | 6.6K | ||
| Estudio-de-prevalenc..> | 2024-09-20 15:22 | 6.6K | ||
| S1-150x150.jpg | 2024-09-23 12:40 | 6.6K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:40 | 6.7K | ||
| LogoOIM-150x148.jpg | 2024-09-20 14:25 | 6.8K | ||
| GTRMEcuador-150x150.jpg | 2024-09-20 14:20 | 6.9K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:54 | 7.1K | ||
| s14-150x150.jpg | 2024-09-23 12:38 | 7.1K | ||
| Documento-de-consens..> | 2024-09-20 15:38 | 7.2K | ||
| Documento-de-consens..> | 2024-09-20 15:20 | 7.2K | ||
| S12-150x150.jpg | 2024-09-23 12:51 | 7.2K | ||
| S21-150x150.jpg | 2024-09-23 12:51 | 7.3K | ||
| Layout-1-pdf-1-113x1..> | 2024-09-20 15:39 | 7.3K | ||
| Orientaciones-termin..> | 2024-09-20 15:27 | 7.3K | ||
| 4JimmyMedina-150x150..> | 2024-09-23 12:39 | 7.5K | ||
| 5.Ricardo-150x150.jpg | 2024-09-23 12:37 | 7.5K | ||
| ARTE-KIMIRINA-pdf-1-..> | 2024-09-20 15:38 | 7.5K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:26 | 7.6K | ||
| Grupal2-150x150.jpg | 2024-09-23 12:40 | 7.7K | ||
| 4.Ibeth_-150x150.jpg | 2024-09-23 12:37 | 7.7K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:23 | 7.7K | ||
| INFORME2018-150x150.jpg | 2024-09-23 10:29 | 7.9K | ||
| Circulo-white-300x30..> | 2024-09-23 15:42 | 8.0K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:55 | 8.1K | ||
| 6Vinicio-150x150.jpg | 2024-09-23 12:40 | 8.2K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:31 | 8.3K | ||
| S11-150x150.jpg | 2024-09-23 12:38 | 8.8K | ||
| IndiceDeEstigmaKimir..> | 2024-09-20 15:23 | 9.0K | ||
| Recurso-2LogoRed-150..> | 2024-09-20 14:30 | 9.0K | ||
| LogoMSP.png | 2024-09-20 14:21 | 9.1K | ||
| INDICE-DE-ESTIGMA-Y-..> | 2024-09-20 15:39 | 9.2K | ||
| ARTE-KIMIRINA-pdf-15..> | 2024-09-20 15:16 | 9.2K | ||
| Layout-1-pdf-150x150..> | 2024-09-20 15:26 | 9.3K | ||
| 8.-Majo-150x150.jpg | 2024-09-23 12:37 | 9.3K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:39 | 9.4K | ||
| INFO2023-pdf-240x300..> | 2024-09-23 10:39 | 9.5K | ||
| Fondo-de-Pantalla-Or..> | 2024-09-17 15:28 | 9.6K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:24 | 9.7K | ||
| 3.Tito_-150x150.jpg | 2024-09-23 12:36 | 9.7K | ||
| 7Park-150x150.jpg | 2024-09-23 12:39 | 9.9K | ||
| AFD_logo-150x150.png | 2024-09-20 14:26 | 10K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:21 | 10K | ||
| Recurso-10IconosEspe..> | 2024-09-23 11:28 | 10K | ||
| Compartir-informes-K..> | 2024-09-20 15:20 | 10K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:39 | 10K | ||
| Recurso-313Quienes-s..> | 2024-09-18 11:49 | 10K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:39 | 10K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:25 | 10K | ||
| GTRMEcuador-300x135.jpg | 2024-09-20 14:20 | 11K | ||
| Accion-acelerada-par..> | 2024-09-20 15:38 | 11K | ||
| 3DayanaQuimi-300x169..> | 2024-09-23 12:39 | 11K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:49 | 11K | ||
| Accion-acelerada-par..> | 2024-09-20 15:18 | 11K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:52 | 11K | ||
| paris_logo-portada-1..> | 2024-09-20 14:23 | 11K | ||
| Recurso-313Quienes-s..> | 2024-09-18 11:49 | 11K | ||
| LogoOIM.jpg | 2024-09-20 14:25 | 11K | ||
| 6.-Park-150x150.jpg | 2024-09-23 12:39 | 12K | ||
| Estudio-de-prevalenc..> | 2024-09-20 15:39 | 12K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:40 | 12K | ||
| LogoOIM-300x130.jpg | 2024-09-20 14:25 | 12K | ||
| Recurso-10IconosEspe..> | 2024-09-23 11:28 | 12K | ||
| Orientaciones-termin..> | 2024-09-20 15:27 | 12K | ||
| Orientaciones-termin..> | 2024-09-20 15:39 | 12K | ||
| Estudio-de-prevalenc..> | 2024-09-20 15:22 | 12K | ||
| Compartir-Informes-1..> | 2024-09-20 15:18 | 12K | ||
| Recurso-308TDRS-150x..> | 2024-09-18 09:34 | 12K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:39 | 12K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:26 | 12K | ||
| Recurso-11IconosEspe..> | 2024-09-23 11:28 | 12K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:39 | 13K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:23 | 13K | ||
| S1-300x169.jpg | 2024-09-23 12:40 | 13K | ||
| Recurso-11IconosEspe..> | 2024-09-23 11:28 | 13K | ||
| 16-Guia-Para-orienta..> | 2024-09-20 15:38 | 13K | ||
| S12-300x169.jpg | 2024-09-23 12:51 | 13K | ||
| PFAC-ES-300x96.png | 2024-09-20 14:31 | 13K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:39 | 13K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:26 | 14K | ||
| s14-300x169.jpg | 2024-09-23 12:38 | 14K | ||
| Perfil_TrabajoSexual..> | 2024-09-20 15:40 | 14K | ||
| 4.Ibeth_-300x169.jpg | 2024-09-23 12:37 | 14K | ||
| paris_logo-portada-3..> | 2024-09-20 14:23 | 14K | ||
| IndiceDeEstigmaKimir..> | 2024-09-20 15:23 | 14K | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:39 | 14K | ||
| INFORME-ANUAL-2018-K..> | 2024-09-23 10:31 | 14K | ||
| S21-300x169.jpg | 2024-09-23 12:51 | 15K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:40 | 15K | ||
| Grupal2-300x169.jpg | 2024-09-23 12:40 | 15K | ||
| Accion-acelerada-par..> | 2024-09-20 15:18 | 15K | ||
| Accion-acelerada-par..> | 2024-09-20 15:38 | 15K | ||
| Recurso-307Documento..> | 2024-09-18 09:22 | 15K | ||
| 5.Ricardo-300x169.jpg | 2024-09-23 12:37 | 15K | ||
| LogoMSP-300x55.png | 2024-09-20 14:21 | 15K | ||
| 4JimmyMedina-300x169..> | 2024-09-23 12:39 | 15K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:39 | 16K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:22 | 16K | ||
| 6Vinicio-300x169.jpg | 2024-09-23 12:39 | 16K | ||
| INFORME2018-237x300.jpg | 2024-09-23 10:29 | 16K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:38 | 16K | ||
| ARTE-KIMIRINA-pdf-30..> | 2024-09-20 15:16 | 16K | ||
| ARTE-KIMIRINA-pdf-1-..> | 2024-09-20 15:38 | 16K | ||
| Effects-of-the-Front..> | 2024-09-20 15:38 | 16K | ||
| Recurso-312Quienes-s..> | 2024-09-18 11:38 | 16K | ||
| S11-300x169.jpg | 2024-09-23 12:38 | 17K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:55 | 17K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:29 | 17K | ||
| Uso-inconsistente-de..> | 2024-09-20 15:30 | 17K | ||
| Depression-and-Oral-..> | 2024-09-20 15:38 | 18K | ||
| 3-ecuador-pdf-232x30..> | 2024-09-20 15:38 | 18K | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:28 | 18K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:40 | 18K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:40 | 18K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:49 | 18K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:52 | 18K | ||
| Perfil_TrabajoSexual..> | 2024-09-20 15:28 | 19K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:28 | 19K | ||
| Fondo-de-Pantalla-Or..> | 2024-09-17 15:28 | 19K | ||
| Depression-and-Oral-..> | 2024-09-20 15:37 | 19K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:31 | 19K | ||
| Effects-of-the-Front..> | 2024-09-20 15:36 | 19K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:29 | 19K | ||
| AFD_logo-300x133.png | 2024-09-20 14:26 | 20K | ||
| Recurso-312Quienes-s..> | 2024-09-18 11:38 | 20K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:31 | 20K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:31 | 20K | ||
| 7Park-300x169.jpg | 2024-09-23 12:39 | 20K | ||
| 8.-Majo-300x169.jpg | 2024-09-23 12:37 | 21K | ||
| Recurso-307Documento..> | 2024-09-18 09:13 | 21K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:49 | 21K | ||
| Recurso-2LogoRed-220..> | 2024-09-20 14:30 | 21K | ||
| 3.Tito_-300x169.jpg | 2024-09-23 12:36 | 21K | ||
| Recurso-10IconosEspe..> | 2024-09-23 11:28 | 22K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:52 | 22K | ||
| untitled-pdf-1-112x1..> | 2024-09-20 15:40 | 23K | ||
| Recurso-313Quienes-s..> | 2024-09-18 11:49 | 23K | ||
| Recurso-2LogoRed.png | 2024-09-20 14:30 | 23K | ||
| Recurso-307Nuestros-..> | 2024-09-17 16:04 | 24K | ||
| Circulo-white-768x76..> | 2024-09-23 15:42 | 24K | ||
| 6.-Park-300x169.jpg | 2024-09-23 12:39 | 24K | ||
| Layout-1-pdf-1-226x3..> | 2024-09-20 15:39 | 25K | ||
| Layout-1-pdf-226x300..> | 2024-09-20 15:26 | 25K | ||
| Recurso-308TDRS-300x..> | 2024-09-18 09:34 | 25K | ||
| untitled-pdf-150x150..> | 2024-09-20 15:30 | 25K | ||
| Uso-inconsistente-de..> | 2024-09-20 15:30 | 25K | ||
| Recurso-306Nuestros-..> | 2024-09-17 15:57 | 26K | ||
| Recurso-11IconosEspe..> | 2024-09-23 11:28 | 27K | ||
| Recurso-311Quienes-s..> | 2024-09-18 10:23 | 28K | ||
| Recurso-312Quienes-s..> | 2024-09-18 11:38 | 28K | ||
| Depression-and-Oral-..> | 2024-09-20 15:38 | 28K | ||
| paris_logo-portada-7..> | 2024-09-20 14:23 | 28K | ||
| Perfil_TrabajoSexual..> | 2024-09-20 15:28 | 29K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:29 | 30K | ||
| Circulo-white.png | 2024-09-23 15:42 | 30K | ||
| Depression-and-Oral-..> | 2024-09-20 15:37 | 30K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:24 | 32K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:29 | 32K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:30 | 32K | ||
| untitled-pdf-1-225x3..> | 2024-09-20 15:40 | 33K | ||
| Circulo-white-1024x1..> | 2024-09-23 15:42 | 34K | ||
| Effects-of-the-Front..> | 2024-09-20 15:36 | 34K | ||
| Recurso-307Documento..> | 2024-09-18 09:13 | 34K | ||
| Recurso-307Documento..> | 2024-09-18 09:22 | 34K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:28 | 34K | ||
| 16-Guia-Para-orienta..> | 2024-09-20 15:17 | 35K | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:23 | 35K | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:28 | 35K | ||
| untitled-pdf-225x300..> | 2024-09-20 15:30 | 35K | ||
| GTRMEcuador.jpg | 2024-09-20 14:20 | 36K | ||
| Compartir-Informes-1..> | 2024-09-20 15:38 | 37K | ||
| Recurso-308TDRS.png | 2024-09-18 09:34 | 40K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:39 | 40K | ||
| Compartir-Informes-1..> | 2024-09-20 15:38 | 41K | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:40 | 41K | ||
| PFAC-ES-768x245.png | 2024-09-20 14:31 | 42K | ||
| paris_logo-portada.jpg | 2024-09-20 14:23 | 42K | ||
| Recurso-8LineadeTiem..> | 2024-09-23 11:05 | 43K | ||
| Recurso-6LineadeTiem..> | 2024-09-23 10:59 | 43K | ||
| 16-Guia-Para-orienta..> | 2024-09-20 15:38 | 43K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:24 | 43K | ||
| Recurso-13LineaDelTi..> | 2024-09-23 11:56 | 43K | ||
| Recurso-310Quienes-s..> | 2024-09-18 10:16 | 43K | ||
| Recurso-5LineadeTiem..> | 2024-09-23 10:58 | 43K | ||
| Recurso-7LineadeTiem..> | 2024-09-23 10:58 | 43K | ||
| AFD_logo.png | 2024-09-20 14:26 | 44K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:39 | 44K | ||
| Recurso-12LineaDelTi..> | 2024-09-23 11:56 | 44K | ||
| Recurso-307Documento..> | 2024-09-18 09:22 | 44K | ||
| Recurso-311Quienes-s..> | 2024-09-18 10:23 | 45K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:24 | 45K | ||
| Recurso-306Nuestros-..> | 2024-09-17 15:57 | 45K | ||
| INFO2023-pdf-819x102..> | 2024-09-23 10:39 | 45K | ||
| Recurso-307Nuestros-..> | 2024-09-17 16:04 | 45K | ||
| INDICE-DE-ESTIGMA-Y-..> | 2024-09-20 15:39 | 45K | ||
| Recurso-8LineadeTiem..> | 2024-09-23 11:05 | 46K | ||
| 3DayanaQuimi-768x432..> | 2024-09-23 12:39 | 46K | ||
| Recurso-13LineaDelTi..> | 2024-09-23 11:56 | 46K | ||
| Recurso-6LineadeTiem..> | 2024-09-23 10:59 | 46K | ||
| Recurso-12LineaDelTi..> | 2024-09-23 11:56 | 46K | ||
| Recurso-311Quienes-s..> | 2024-09-18 10:23 | 46K | ||
| Recurso-7LineadeTiem..> | 2024-09-23 10:58 | 46K | ||
| Recurso-5LineadeTiem..> | 2024-09-23 10:58 | 46K | ||
| Recurso-307Documento..> | 2024-09-18 09:13 | 47K | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:39 | 47K | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:40 | 48K | ||
| Accion-acelerada-par..> | 2024-09-20 15:38 | 48K | ||
| Orientaciones-termin..> | 2024-09-20 15:39 | 48K | ||
| Orientaciones-termin..> | 2024-09-20 15:27 | 48K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:21 | 49K | ||
| INFORME2018.jpg | 2024-09-23 10:29 | 49K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:39 | 50K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:39 | 50K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:21 | 50K | ||
| Recurso-307Nuestros-..> | 2024-09-17 16:04 | 51K | ||
| Orientaciones-termin..> | 2024-09-20 15:27 | 52K | ||
| ARTE-KIMIRINA-pdf-76..> | 2024-09-20 15:16 | 52K | ||
| Documento-de-consens..> | 2024-09-20 15:38 | 52K | ||
| Documento-de-consens..> | 2024-09-20 15:20 | 52K | ||
| S1-768x432.jpg | 2024-09-23 12:40 | 53K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:39 | 53K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:25 | 53K | ||
| s14-768x432.jpg | 2024-09-23 12:39 | 53K | ||
| 4.Ibeth_-768x432.jpg | 2024-09-23 12:37 | 55K | ||
| Documento-de-consens..> | 2024-09-20 15:20 | 55K | ||
| Recurso-306Nuestros-..> | 2024-09-17 15:57 | 56K | ||
| AFD_logo-768x340.png | 2024-09-20 14:26 | 57K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:25 | 57K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:23 | 59K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:39 | 59K | ||
| PFAC-ES-1024x327.png | 2024-09-20 14:31 | 59K | ||
| Estimates-of-global-..> | 2024-09-20 15:39 | 61K | ||
| S21-768x432.jpg | 2024-09-23 12:51 | 62K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:49 | 62K | ||
| S12-768x432.jpg | 2024-09-23 12:51 | 62K | ||
| Recurso-309Quienes-s..> | 2024-09-18 09:52 | 64K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:23 | 64K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:29 | 64K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:24 | 64K | ||
| Estudio-de-prevalenc..> | 2024-09-20 15:39 | 65K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:29 | 67K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:39 | 67K | ||
| Effects-of-the-Front..> | 2024-09-20 15:36 | 67K | ||
| 6Vinicio-768x432.jpg | 2024-09-23 12:40 | 68K | ||
| Grupal2-768x432.jpg | 2024-09-23 12:40 | 68K | ||
| 5.Ricardo-768x432.jpg | 2024-09-23 12:37 | 69K | ||
| Recurso-310Quienes-s..> | 2024-09-18 10:16 | 69K | ||
| Recurso-13LineaDelTi..> | 2024-09-23 11:56 | 70K | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:24 | 70K | ||
| Recurso-8LineadeTiem..> | 2024-09-23 11:05 | 71K | ||
| Compartir-Informes-1..> | 2024-09-20 15:38 | 72K | ||
| Recurso-6LineadeTiem..> | 2024-09-23 10:59 | 73K | ||
| 3DayanaQuimi-1024x57..> | 2024-09-23 12:39 | 73K | ||
| Estimates-of-global-..> | 2024-09-20 15:39 | 74K | ||
| ARTE-KIMIRINA-pdf-10..> | 2024-09-20 15:16 | 74K | ||
| ARTE-KIMIRINA-pdf-1-..> | 2024-09-20 15:38 | 74K | ||
| Recurso-12LineaDelTi..> | 2024-09-23 11:56 | 74K | ||
| INDICE-DE-ESTIGMA-Y-..> | 2024-09-20 15:39 | 74K | ||
| Orientaciones-termin..> | 2024-09-20 15:39 | 76K | ||
| Recurso-7LineadeTiem..> | 2024-09-23 10:58 | 77K | ||
| Recurso-5LineadeTiem..> | 2024-09-23 10:58 | 77K | ||
| Orientaciones-termin..> | 2024-09-20 15:27 | 77K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:55 | 77K | ||
| Accion-acelerada-par..> | 2024-09-20 15:38 | 78K | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:23 | 79K | ||
| S11-768x432.jpg | 2024-09-23 12:38 | 80K | ||
| 4JimmyMedina-768x432..> | 2024-09-23 12:39 | 81K | ||
| 16-Guia-Para-orienta..> | 2024-09-20 15:17 | 82K | ||
| Recurso-308TDRS-768x..> | 2024-09-18 09:34 | 82K | ||
| S1-1024x576.jpg | 2024-09-23 12:40 | 83K | ||
| s14-1024x576.jpg | 2024-09-23 12:38 | 83K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:39 | 83K | ||
| 4.Ibeth_-1024x576.jpg | 2024-09-23 12:37 | 84K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:21 | 84K | ||
| Fondo-de-Pantalla-Or..> | 2024-09-17 15:28 | 86K | ||
| 8.-Majo-768x432.jpg | 2024-09-23 12:37 | 88K | ||
| Recurso-13LineaDelTi..> | 2024-09-23 11:56 | 90K | ||
| Recurso-8LineadeTiem..> | 2024-09-23 11:05 | 91K | ||
| INFORME-ANUAL-2018-K..> | 2024-09-23 10:31 | 91K | ||
| PFAC-ES-1536x490.png | 2024-09-20 14:31 | 92K | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:40 | 93K | ||
| Recurso-6LineadeTiem..> | 2024-09-23 10:59 | 94K | ||
| Documento-de-consens..> | 2024-09-20 15:38 | 94K | ||
| Documento-de-consens..> | 2024-09-20 15:20 | 94K | ||
| Recurso-12LineaDelTi..> | 2024-09-23 11:56 | 95K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:39 | 96K | ||
| indice-de-estigma-y-..> | 2024-09-20 15:25 | 96K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:31 | 96K | ||
| S21-1024x576.jpg | 2024-09-23 12:51 | 97K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:26 | 97K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:39 | 97K | ||
| S12-1024x576.jpg | 2024-09-23 12:51 | 100K | ||
| Recurso-7LineadeTiem..> | 2024-09-23 10:58 | 100K | ||
| Recurso-5LineadeTiem..> | 2024-09-23 10:58 | 100K | ||
| 3-ecuador.pdf | 2024-09-20 15:38 | 101K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:23 | 102K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:39 | 102K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:28 | 102K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:40 | 103K | ||
| Compartir-Informes-1..> | 2024-09-20 15:38 | 103K | ||
| 3.Tito_-768x432.jpg | 2024-09-23 12:36 | 103K | ||
| Recurso-310Quienes-s..> | 2024-09-18 10:16 | 104K | ||
| 7Park-768x432.jpg | 2024-09-23 12:39 | 105K | ||
| 6Vinicio-1024x576.jpg | 2024-09-23 12:40 | 107K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:26 | 107K | ||
| Effects-of-the-Front..> | 2024-09-20 15:38 | 108K | ||
| Recurso-307Documento..> | 2024-09-18 09:22 | 108K | ||
| Grupal2-1024x576.jpg | 2024-09-23 12:40 | 108K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:26 | 108K | ||
| 5.Ricardo-1024x576.jpg | 2024-09-23 12:37 | 113K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:39 | 113K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:26 | 114K | ||
| Recurso-308TDRS-1024..> | 2024-09-18 09:34 | 114K | ||
| Perfil_TrabajoSexual..> | 2024-09-20 15:40 | 115K | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:40 | 119K | ||
| Estudio-de-prevalenc..> | 2024-09-20 15:39 | 119K | ||
| PFAC-ES-2048x654.png | 2024-09-20 14:31 | 126K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:40 | 126K | ||
| S11-1024x576.jpg | 2024-09-23 12:38 | 129K | ||
| INFORME-ANUAL-2018-K..> | 2024-09-23 10:31 | 129K | ||
| ARTE-KIMIRINA-pdf.jpg | 2024-09-20 15:16 | 131K | ||
| ARTE-KIMIRINA-pdf-1.jpg | 2024-09-20 15:38 | 131K | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:28 | 131K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:39 | 132K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:22 | 132K | ||
| 4JimmyMedina-1024x57..> | 2024-09-23 12:39 | 134K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:40 | 135K | ||
| 8.-Majo-1024x576.jpg | 2024-09-23 12:37 | 135K | ||
| Recurso-13LineaDelTi..> | 2024-09-23 11:56 | 136K | ||
| Recurso-307Documento..> | 2024-09-18 09:13 | 136K | ||
| Recurso-8LineadeTiem..> | 2024-09-23 11:05 | 139K | ||
| 6.-Park-768x432.jpg | 2024-09-23 12:39 | 139K | ||
| Fondo-de-Pantalla-Or..> | 2024-09-17 15:28 | 139K | ||
| Recurso-6LineadeTiem..> | 2024-09-23 10:59 | 141K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:39 | 145K | ||
| untitled.pdf | 2024-09-20 15:40 | 146K | ||
| Recurso-311Quienes-s..> | 2024-09-18 10:23 | 146K | ||
| 3DayanaQuimi-1536x86..> | 2024-09-23 12:39 | 147K | ||
| Recurso-307Documento..> | 2024-09-18 09:22 | 148K | ||
| Recurso-12LineaDelTi..> | 2024-09-23 11:56 | 148K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:38 | 149K | ||
| 4.Ibeth_-1536x864.jpg | 2024-09-23 12:37 | 153K | ||
| untitled-pdf-1-768x1..> | 2024-09-20 15:40 | 153K | ||
| 3-ecuador-pdf-791x10..> | 2024-09-20 15:38 | 153K | ||
| S1-1536x864.jpg | 2024-09-23 12:40 | 155K | ||
| s14-1536x864.jpg | 2024-09-23 12:39 | 156K | ||
| Recurso-7LineadeTiem..> | 2024-09-23 10:59 | 157K | ||
| Recurso-5LineadeTiem..> | 2024-09-23 10:58 | 157K | ||
| PFAC-ES.png | 2024-09-20 14:31 | 159K | ||
| INFO2023-pdf.jpg | 2024-09-23 10:39 | 160K | ||
| 3.Tito_-1024x576.jpg | 2024-09-23 12:36 | 163K | ||
| Depression-and-Oral-..> | 2024-09-20 15:38 | 163K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:40 | 164K | ||
| untitled-pdf-768x102..> | 2024-09-20 15:30 | 172K | ||
| Recurso-307Nuestros-..> | 2024-09-17 16:04 | 173K | ||
| 7Park-1024x576.jpg | 2024-09-23 12:39 | 176K | ||
| Layout-1-pdf-768x102..> | 2024-09-20 15:26 | 178K | ||
| Layout-1-pdf-1-770x1..> | 2024-09-20 15:39 | 181K | ||
| Layout-1-pdf-770x102..> | 2024-09-20 15:26 | 181K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:38 | 184K | ||
| S21-1536x864.jpg | 2024-09-23 12:51 | 184K | ||
| Recurso-306Nuestros-..> | 2024-09-17 15:57 | 190K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:39 | 190K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:26 | 190K | ||
| S12-1536x864.jpg | 2024-09-23 12:51 | 192K | ||
| Effects-of-the-Front..> | 2024-09-20 15:38 | 197K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:40 | 197K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:40 | 199K | ||
| Grupal2-1536x864.jpg | 2024-09-23 12:40 | 206K | ||
| 6Vinicio-1536x864.jpg | 2024-09-23 12:40 | 208K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:24 | 211K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:40 | 223K | ||
| 5.Ricardo-1536x864.jpg | 2024-09-23 12:37 | 225K | ||
| Estimates-of-global-..> | 2024-09-20 15:39 | 233K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:39 | 235K | ||
| Perfil_TrabajoSexual..> | 2024-09-20 15:40 | 236K | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:26 | 236K | ||
| 6.-Park-1024x576.jpg | 2024-09-23 12:39 | 237K | ||
| 4.Ibeth_-2048x1153.jpg | 2024-09-23 12:37 | 239K | ||
| S1-2048x1153.jpg | 2024-09-23 12:40 | 244K | ||
| 8.-Majo-1536x864.jpg | 2024-09-23 12:37 | 244K | ||
| s14-2048x1153.jpg | 2024-09-23 12:39 | 248K | ||
| S11-1536x864.jpg | 2024-09-23 12:38 | 253K | ||
| 3DayanaQuimi-2048x11..> | 2024-09-23 12:39 | 253K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:39 | 259K | ||
| 4JimmyMedina-1536x86..> | 2024-09-23 12:39 | 262K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:39 | 264K | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:22 | 264K | ||
| A-Continuing-HIV-Epi..> | 2024-09-20 15:38 | 266K | ||
| untitled-pdf-1.jpg | 2024-09-20 15:40 | 267K | ||
| Fondo-de-Pantalla-Or..> | 2024-09-17 15:28 | 274K | ||
| 3-ecuador-pdf.jpg | 2024-09-20 15:38 | 287K | ||
| Depression-and-Oral-..> | 2024-09-20 15:38 | 293K | ||
| S21-2048x1153.jpg | 2024-09-23 12:51 | 294K | ||
| Risk-Factors-Associa..> | 2024-09-20 15:40 | 298K | ||
| Syphilis_and_Herpes_..> | 2024-09-20 15:40 | 302K | ||
| 3.Tito_-1536x864.jpg | 2024-09-23 12:36 | 303K | ||
| S12-2048x1153.jpg | 2024-09-23 12:51 | 304K | ||
| untitled-pdf.jpg | 2024-09-20 15:30 | 307K | ||
| Layout-1-pdf-1.jpg | 2024-09-20 15:39 | 320K | ||
| Layout-1-pdf.jpg | 2024-09-20 15:26 | 320K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:40 | 324K | ||
| Grupal2-2048x1153.jpg | 2024-09-23 12:40 | 326K | ||
| 16-Guia-Para-orienta..> | 2024-09-20 15:38 | 332K | ||
| 6Vinicio-2048x1153.jpg | 2024-09-23 12:40 | 336K | ||
| 4.Ibeth_-scaled.jpg | 2024-09-23 12:37 | 340K | ||
| S1-scaled.jpg | 2024-09-23 12:40 | 346K | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:23 | 355K | ||
| 7Park-1536x864.jpg | 2024-09-23 12:39 | 358K | ||
| s14-scaled.jpg | 2024-09-23 12:38 | 358K | ||
| 5.Ricardo-2048x1153.jpg | 2024-09-23 12:37 | 370K | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:39 | 371K | ||
| 8.-Majo-2048x1153.jpg | 2024-09-23 12:37 | 374K | ||
| Recurso-13LineaDelTi..> | 2024-09-23 11:56 | 377K | ||
| 3DayanaQuimi-scaled.jpg | 2024-09-23 12:39 | 380K | ||
| Depression-and-Oral-..> | 2024-09-20 15:38 | 382K | ||
| Recurso-8LineadeTiem..> | 2024-09-23 11:05 | 388K | ||
| Uptake-of-pre-exposu..> | 2024-09-20 15:40 | 390K | ||
| Estimates-of-global-..> | 2024-09-20 15:39 | 394K | ||
| Perfil_TrabajoSexual..> | 2024-09-20 15:40 | 397K | ||
| Recurso-6LineadeTiem..> | 2024-09-23 10:59 | 398K | ||
| S11-2048x1153.jpg | 2024-09-23 12:38 | 409K | ||
| 16-Guia-Para-orienta..> | 2024-09-20 15:38 | 412K | ||
| 4JimmyMedina-2048x11..> | 2024-09-23 12:39 | 419K | ||
| Fondo-de-Pantalla-Or..> | 2024-09-17 15:28 | 421K | ||
| S21-scaled.jpg | 2024-09-23 12:51 | 423K | ||
| Recurso-12LineaDelTi..> | 2024-09-23 11:56 | 428K | ||
| S12-scaled.jpg | 2024-09-23 12:51 | 431K | ||
| Effects-of-the-Front..> | 2024-09-20 15:38 | 432K | ||
| Orientaciones-termin..> | 2024-09-20 15:39 | 450K | ||
| Recurso-7LineadeTiem..> | 2024-09-23 10:58 | 450K | ||
| Recurso-5LineadeTiem..> | 2024-09-23 10:58 | 451K | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:39 | 458K | ||
| Grupal2-scaled.jpg | 2024-09-23 12:40 | 459K | ||
| 3.Tito_-2048x1153.jpg | 2024-09-23 12:36 | 473K | ||
| 6Vinicio-scaled.jpg | 2024-09-23 12:39 | 483K | ||
| 6.-Park-1536x864.jpg | 2024-09-23 12:39 | 500K | ||
| gesida-guiasclinicas..> | 2024-09-20 15:39 | 512K | ||
| 8.-Majo-scaled.jpg | 2024-09-23 12:37 | 521K | ||
| Accion-acelerada-par..> | 2024-09-20 15:38 | 541K | ||
| Documento-de-consens..> | 2024-09-20 15:38 | 541K | ||
| 5.Ricardo-scaled.jpg | 2024-09-23 12:37 | 547K | ||
| Mapeo-programatico-M..> | 2024-09-20 15:39 | 556K | ||
| S11-scaled.jpg | 2024-09-23 12:38 | 587K | ||
| 7Park-2048x1153.jpg | 2024-09-23 12:39 | 589K | ||
| 4JimmyMedina-scaled.jpg | 2024-09-23 12:39 | 600K | ||
| LOS-CINCO-ANOS-DE-LA..> | 2024-09-20 15:39 | 628K | ||
| 3.Tito_-scaled.jpg | 2024-09-23 12:36 | 664K | ||
| Preexposure-Chemopro..> | 2024-09-20 15:40 | 677K | ||
| 6.-Park-2048x1153.jpg | 2024-09-23 12:39 | 841K | ||
| 7Park-scaled.jpg | 2024-09-23 12:39 | 855K | ||
| Estigma-y-discrimina..> | 2024-09-20 15:39 | 913K | ||
| Layout-1.pdf | 2024-09-20 15:39 | 939K | ||
| ARTE-KIMIRINA.pdf | 2024-09-20 15:38 | 1.0M | ||
| 6.-Park-scaled.jpg | 2024-09-23 12:39 | 1.2M | ||
| indice-de-estigma-y-..> | 2024-09-20 15:39 | 1.2M | ||
| Grupal2.jpg | 2024-09-23 12:40 | 1.2M | ||
| S12.jpg | 2024-09-23 12:51 | 1.3M | ||
| Compartir-Informes-1..> | 2024-09-20 15:38 | 1.4M | ||
| 4JimmyMedina.jpg | 2024-09-23 12:39 | 1.7M | ||
| INDICE-DE-ESTIGMA-Y-..> | 2024-09-20 15:39 | 1.7M | ||
| Indice-de-estigma-y-..> | 2024-09-20 15:39 | 1.8M | ||
| PLAN-NACIONAL-DE-SS-..> | 2024-09-20 15:40 | 2.2M | ||
| 16-Guia-Para-orienta..> | 2024-09-20 15:38 | 2.3M | ||
| Estudio-de-prevalenc..> | 2024-09-20 15:39 | 2.5M | ||
| Guia_Tranzado-la-Can..> | 2024-09-20 15:39 | 4.4M | ||
| Estrategia-ONUSIDA-2..> | 2024-09-20 15:39 | 4.9M | ||
| INFO2023.pdf | 2024-09-23 10:39 | 5.1M | ||
| S1.jpg | 2024-09-23 12:40 | 5.5M | ||
| MODELO-DE-ATENCION-I..> | 2024-09-20 15:39 | 5.9M | ||
| 3DayanaQuimi.jpg | 2024-09-23 12:39 | 6.1M | ||
| 4.Ibeth_.jpg | 2024-09-23 12:37 | 6.7M | ||
| 6Vinicio.jpg | 2024-09-23 12:39 | 7.2M | ||
| s14.jpg | 2024-09-23 12:38 | 7.2M | ||
| 8.-Majo.jpg | 2024-09-23 12:37 | 8.1M | ||
| S11.jpg | 2024-09-23 12:38 | 8.1M | ||
| S21.jpg | 2024-09-23 12:51 | 8.2M | ||
| 3.Tito_.jpg | 2024-09-23 12:36 | 8.6M | ||
| 5.Ricardo.jpg | 2024-09-23 12:37 | 9.6M | ||
| 7Park.jpg | 2024-09-23 12:39 | 9.8M | ||
| 6.-Park.jpg | 2024-09-23 12:39 | 13M | ||
| Estimates-of-global-..> | 2024-09-20 15:39 | 13M | ||
| INFORME-ANUAL-2018-K..> | 2024-09-23 10:31 | 18M | ||
